Cargando…

Preanalytic depletion of medicinal anti-CD38 antibody from patient plasma for immunohematology testing

Monoclonal antibodies such as daratumumab that target antigens that are also expressed on red blood cells impede blood group typing. The preferred approach to potential transfusion is to do prior extensive antigen typing of patients' red cells; however, this is not always possible. Ehrend et al...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehrend, Elisabeth, Manns, Patricia, Harenkamp, Sabine, Seifried, Erhard, Geisen, Christof, Bonig, Halvard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414259/
https://www.ncbi.nlm.nih.gov/pubmed/34086874
http://dx.doi.org/10.1182/blood.2021011396
_version_ 1783747766842818560
author Ehrend, Elisabeth
Manns, Patricia
Harenkamp, Sabine
Seifried, Erhard
Geisen, Christof
Bonig, Halvard
author_facet Ehrend, Elisabeth
Manns, Patricia
Harenkamp, Sabine
Seifried, Erhard
Geisen, Christof
Bonig, Halvard
author_sort Ehrend, Elisabeth
collection PubMed
description Monoclonal antibodies such as daratumumab that target antigens that are also expressed on red blood cells impede blood group typing. The preferred approach to potential transfusion is to do prior extensive antigen typing of patients' red cells; however, this is not always possible. Ehrend et al describe a technique for absorbing the antibodies from serum to allow accurate red cell typing for transfusion.
format Online
Article
Text
id pubmed-8414259
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-84142592022-09-02 Preanalytic depletion of medicinal anti-CD38 antibody from patient plasma for immunohematology testing Ehrend, Elisabeth Manns, Patricia Harenkamp, Sabine Seifried, Erhard Geisen, Christof Bonig, Halvard Blood Letter to Blood Monoclonal antibodies such as daratumumab that target antigens that are also expressed on red blood cells impede blood group typing. The preferred approach to potential transfusion is to do prior extensive antigen typing of patients' red cells; however, this is not always possible. Ehrend et al describe a technique for absorbing the antibodies from serum to allow accurate red cell typing for transfusion. American Society of Hematology 2021-09-02 /pmc/articles/PMC8414259/ /pubmed/34086874 http://dx.doi.org/10.1182/blood.2021011396 Text en © 2021 by The American Society of Hematology This article is made available via the PMC Open Access Subset for unrestricted reuse and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Letter to Blood
Ehrend, Elisabeth
Manns, Patricia
Harenkamp, Sabine
Seifried, Erhard
Geisen, Christof
Bonig, Halvard
Preanalytic depletion of medicinal anti-CD38 antibody from patient plasma for immunohematology testing
title Preanalytic depletion of medicinal anti-CD38 antibody from patient plasma for immunohematology testing
title_full Preanalytic depletion of medicinal anti-CD38 antibody from patient plasma for immunohematology testing
title_fullStr Preanalytic depletion of medicinal anti-CD38 antibody from patient plasma for immunohematology testing
title_full_unstemmed Preanalytic depletion of medicinal anti-CD38 antibody from patient plasma for immunohematology testing
title_short Preanalytic depletion of medicinal anti-CD38 antibody from patient plasma for immunohematology testing
title_sort preanalytic depletion of medicinal anti-cd38 antibody from patient plasma for immunohematology testing
topic Letter to Blood
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414259/
https://www.ncbi.nlm.nih.gov/pubmed/34086874
http://dx.doi.org/10.1182/blood.2021011396
work_keys_str_mv AT ehrendelisabeth preanalyticdepletionofmedicinalanticd38antibodyfrompatientplasmaforimmunohematologytesting
AT mannspatricia preanalyticdepletionofmedicinalanticd38antibodyfrompatientplasmaforimmunohematologytesting
AT harenkampsabine preanalyticdepletionofmedicinalanticd38antibodyfrompatientplasmaforimmunohematologytesting
AT seifriederhard preanalyticdepletionofmedicinalanticd38antibodyfrompatientplasmaforimmunohematologytesting
AT geisenchristof preanalyticdepletionofmedicinalanticd38antibodyfrompatientplasmaforimmunohematologytesting
AT bonighalvard preanalyticdepletionofmedicinalanticd38antibodyfrompatientplasmaforimmunohematologytesting